TheBrief.Health

Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC

Episode Summary

Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.